Pseudo-Ischemic ECG Changes in a Patient With Profound Mixed Metabolic Acidosis Due to Metformin Use

Read full text Summarise with VIRAT
Authors: John J. Grant, David P. Wilson, John T. Schindler
Cited by: 0
References: 9

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Metformin-induced lactic acidosis can cause electrocardiographic (ECG) changes and precipitate cardiac arrest. CASE SUMMARY: A 58-year-old woman presented to the emergency department after a ventricular fibrillation arrest. Laboratory findings on admission showed severe lactic acidosis, and ECG showed ischemic changes concerning for a ST-segment elevation myocardial infarction. After treatment of the patient's sepsis, urinary tract infection, and acute kidney injury, she improved, and the pseudo-ischemic ECG changes resolved. DISCUSSION: Metformin is a known instigator of lactic acidosis, particularly in patients with renal failure. On rare occasion, such lactic acidosis secondary to metformin can produce lethal arrhythmias. This case demonstrates the need for providers to consider metabolic derangements in patients with ventricular fibrillation arrest and subsequent ECG changes. TAKE-HOME MESSAGE: It is crucial for providers to recognize metabolic acidosis as a precipitator of cardiac arrest and to identify patients who take metformin who are at risk for metformin-associated lactic acidosis.

Fields of Study & Subjects

Cardiac electrophysiology and arrhythmias Renal function and acid-base balance Acute Myocardial Infarction Research

Publication details

Journal / source
JACC Case Reports
Volume
31
Issue
18
Pages
107733–107733
Publication date
31 March 2026
Language
EN